Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Angiodynamics Inc
(NQ:
ANGO
)
7.610
+0.150 (+2.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Angiodynamics Inc
< Previous
1
2
3
4
5
6
7
Next >
Small Caps Lift Stock Futures As Traders Await Inflation Data: Analyst Says 'Now Is A Good Time' To Diversify Portfolios
July 12, 2023
Via
Benzinga
AngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance
July 12, 2023
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics, Disney And 3 Stocks To Watch Heading Into Wednesday
July 12, 2023
With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Investor Optimism Improves Ahead Of Inflation Data
July 12, 2023
The CNN Money Fear and Greed index showed some improvement in overall sentiment among U.S. investors on Tuesday. U.S. stocks closed higher on Tuesday ahead of this week’s key inflation data. The...
Via
Benzinga
AngioDynamics's Earnings: A Preview
July 11, 2023
Via
Benzinga
Why Shares of AngioDynamics Rose Friday
June 09, 2023
The medical technology company sold some of its assets to pay down its debt.
Via
The Motley Fool
Preview: AngioDynamics's Earnings
March 29, 2023
Via
Benzinga
AngioDynamics to Report Fiscal 2023 Fourth Quarter and Full-Year Financial Results on July 12, 2023
June 20, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Future Of Merit Medical Systems: Analyst Predictions On Revenue Growth And Operating Margin Improvement
June 09, 2023
Needham analyst Mike Matson reiterated a Buy rating on the shares of Merit Medical Systems, Inc. (NASDAQ: MMSI),
Via
Benzinga
AngioDynamics Divests Dialysis Portfolio And Biopsy Product Line To Merit Medical Systems For $100M
June 09, 2023
AngioDynamics, Inc. (NASDAQ: ANGO)
Via
Benzinga
AngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million
June 08, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Top 5 Health Care Stocks That Are Preparing To Pump In Q2
April 26, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023
April 17, 2023
Via
Benzinga
AngioDynamics to Present at the Needham Virtual Healthcare Conference
April 11, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Wall Street Thinks This Small-Cap Stock Can Double in Value
April 04, 2023
Analysts are projecting a huge rebound from this beaten-down stock in the next 12 months.
Via
The Motley Fool
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 31, 2023
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.
Via
Benzinga
Dow Rises 100 Points; Accelerate Diagnostics Shares Spike Higher
March 30, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 100 points on Thursday. The Dow traded up 0.31% to 32,819.16 while the NASDAQ rose 0.63% to 12,001.83. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 30, 2023
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 30, 2023
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...
Via
Benzinga
Why AngioDynamics Shares Are Trading Lower Today
March 30, 2023
AngioDynamics (NASDAQ: ANGO) shares are trading lower on Thursday after the company reported worse-than-expected Q3 revenue and reduced its 2023 revenue guidance.
Via
Benzinga
US Stocks Open Higher; Dow Jumps 150 Points
March 30, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Thursday. Following the market opening Thursday, the Dow traded up 0.48% to 32,874.88 while the NASDAQ rose 0.68%...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 30, 2023
Via
Benzinga
AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance
March 30, 2023
From
AngioDynamics, Inc.
Via
Business Wire
US Stocks Eye Strong Q1 Finish As Futures Point To Higher Open: Jobless Claims, GDP Data In Focus
March 30, 2023
The positive momentum witnessed in recent sessions could spill over into Thursday as the index futures point to a moderately higher opening.
Via
Benzinga
AngioDynamics to Report Fiscal 2023 Third Quarter Financial Results on March 30, 2023
March 13, 2023
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Participate in Three Investor Conferences in March
February 28, 2023
From
AngioDynamics, Inc.
Via
Business Wire
American Airlines, Morgan Stanley And 2 Other Stocks Insiders Are Selling
February 02, 2023
The Nasdaq jumped by around 2% on Wednesday following the Fed’s rate decision. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Is This Under-the-Radar Growth Stock a Buy?
January 19, 2023
This company is a small player in the steadily growing medtech industry.
Via
The Motley Fool
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 05, 2023
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...
Via
Benzinga
AngioDynamics Reports Fiscal 2023 Second Quarter Financial Results; Reaffirms Guidance
January 05, 2023
From
AngioDynamics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.